Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management

• المؤلفون الرئيسيون: Sukhbir Singh (مؤلف), Neha Tiwary (مؤلف), Neelam Sharma (مؤلف), Tapan Behl (مؤلف), Anita Antil (مؤلف), Md. Khalid Anwer (مؤلف), Seema Ramniwas (مؤلف), Monika Sachdeva (مؤلف), Gehan M. Elossaily (مؤلف), Monica Gulati (مؤلف), Shreesh Ohja (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2024-02-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Disease-modifying anti-rheumatic drugs (DMARDs) is a class of anti-rheumatic medicines that are frequently prescribed to patients suffering from rheumatoid arthritis (RA). Methotrexate, sulfasalazine, hydroxychloroquine, and azathioprine are examples of non-biologic DMARDs that are being used for al...